Cochlear Limited (CHEOF)
OTCMKTS
· Delayed Price · Currency is USD
174.55
+0.05 (0.03%)
Jun 12, 2025, 9:30 AM EDT
Cochlear Revenue
Cochlear had revenue of 1.17B AUD in the half year ending December 30, 2024, with 32.38% growth. This brings the company's revenue in the last twelve months to 2.31B, up 7.42% year-over-year. In the fiscal year ending June 30, 2024, Cochlear had annual revenue of 2.24B with 15.47% growth.
Revenue (ttm)
2.31B AUD
Revenue Growth
+7.42%
P/S Ratio
8.10
Revenue / Employee
452.99K AUD
Employees
5,097
Market Cap
11.62B USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
Jun 30, 2020 | 1.32B | -106.10M | -7.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Cochlear News
- 11 days ago - Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™ - PRNewsWire
- 15 days ago - Labor takes $27m stake in breakthrough eye biotech - The Australian Financial Review
- 3 months ago - Hearing Implants Global Strategic Business Report 2025: Market to Reach $4.9 Billion by 2030 - Increasing Adoption of Cochlear Implants Expands Opportunities - GlobeNewsWire
- 3 months ago - Assessment of the $6.63 Billion Cochlear Implants Market, 2034: Emerging Markets, such as Asia-Pacific, Latin America and Africa, Present a Significant Growth Opportunity - GlobeNewsWire
- 3 months ago - Cochlear Named Most Trustworthy Healthcare Company in the World - PRNewsWire
- 3 months ago - Cochlear North America Celebrates International Cochlear Implant Day by Announcing 2025 Academic Scholarship Winners - PRNewsWire
- 4 months ago - Cochlear Implants Market to Hit US$4.73 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™. - GlobeNewsWire
- 4 months ago - Cochlear reports 1H results - Seeking Alpha